Leveraging Generative AI to Design Therapeutic Antibodies
James Field, founder and CEO of LabGenius, discusses the company’s use of generative AI to discover new therapeutic antibodies, its initial focus on immunotherapies, why he thinks the data the company is generating to train its AI system is a significant point of differentiation.